Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat for Nasal Potential Difference in Cystic Fibrosis
NCT00742092Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Aug 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miglustat in cystic fibrosis (CF), sponsored by Actelion Pharmaceuticals Ltd. Started Aug 2008; status: completed.
02
Drugs
miglustat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00742092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742092.